Several companies requested our support to obtain orphan designation in Japan.
We supported the company to receive orphan designation in Japan in a short time. Yakumed has prepared and led the regulatory strategy and its execution. We arranged and led the meeting with MHLW, prepared and submitted all the required documents, and responded to queries from MHLW until orphan drug designation is received in Japan.
We epitomize the perfect combination of a robust strategy with active communication and effective execution. We are honoured to be a dedicated partner for your success in Japan!